Genetics Generation Advancement Corp. (4160.TWO)

TWD 70.5

(0.14%)

Gross Profit Summary of Genetics Generation Advancement Corp.

  • Genetics Generation Advancement Corp.'s latest annual gross profit in 2023 was 236.83 Million TWD , up 4.59% from previous year.
  • Genetics Generation Advancement Corp.'s latest quarterly gross profit in 2024 Q2 was 76.73 Million TWD , up 14.94% from previous quarter.
  • Genetics Generation Advancement Corp. reported a annual gross profit of 226.43 Million TWD in annual gross profit 2022, up 15.83% from previous year.
  • Genetics Generation Advancement Corp. reported a annual gross profit of 195.49 Million TWD in annual gross profit 2021, up 38.36% from previous year.
  • Genetics Generation Advancement Corp. reported a quarterly gross profit of 66.75 Million TWD for 2024 Q1, up 3.2% from previous quarter.
  • Genetics Generation Advancement Corp. reported a quarterly gross profit of 64.68 Million TWD for 2023 Q4, up 8.85% from previous quarter.

Annual Gross Profit Chart of Genetics Generation Advancement Corp. (2023 - 2019)

Historical Annual Gross Profit of Genetics Generation Advancement Corp. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 236.83 Million TWD 4.59%
2022 226.43 Million TWD 15.83%
2021 195.49 Million TWD 38.36%
2020 141.28 Million TWD -15.71%
2019 167.62 Million TWD 0.0%

Peer Gross Profit Comparison of Genetics Generation Advancement Corp.

Name Gross Profit Gross Profit Difference
BIONET Corp. 638.27 Million TWD 62.895%
DIVA Laboratories, Ltd. 250.77 Million TWD 5.56%
Welgene Biotech Co.,Ltd. 119.71 Million TWD -97.827%
Puriblood Medical Co., Ltd. 6.52 Million TWD -3530.691%
TFBS Bioscience Inc. 77.82 Million TWD -204.295%